Literature DB >> 25472585

Association between polymorphisms of microRNA-binding sites in integrin genes and gastric cancer in Chinese Han population.

Xingbo Song1, Huiyu Zhong, Juan Zhou, Xuejiao Hu, Yi Zhou, Yuanxin Ye, Xiaojun Lu, Jun Wang, Binwu Ying, Lanlan Wang.   

Abstract

Highly elevated expression of integrin has been observed in a variety of malignant tumors. Single nucleotide polymorphisms (SNPs) in the microRNA-binding sites in the 3' UTR region of target genes may result in the level change of target gene expression and subsequently susceptible to diseases, including cancer. In this study, we aimed to investigate the association between polymorphisms of microRNA-binding sites of integrin genes and gastric cancer (GC) in Chinese Han population. Five SNPs of the microRNA-binding sites in the 3' UTR region of integrin genes (rs1062484 C/T in ITGA3, rs17664 A/G in ITGA6, rs3809865 A/T in ITGB3, rs743554 C/T in ITGB4, and rs2675 A/C in ITGB5) were studied using high resolution melting (HRM) analysis in 1000 GC patients and 1000 unrelated controls. The polymorphism of SNP rs2675 was associated with susceptibility of GC [odds ratio (OR) = 0.52, 95% confidence interval (CI) = 0.28-0.97, P = 0.028]. In addition, genotype AA of rs2675 and genotype GG of rs17664 were associated with a lower chance of GC at stage 1b [OR = 0.39 (0.18-0.85), P = 0.009; and OR = 0.37 (0.17-0.78), P = 0.004, respectively]; also, the frequency of allele G of rs17664 was associated with a lower chance of stage 1b tumor [OR = 0.50 (0.26-0.95), P = 0.021]. Furthermore, the frequency of genotype AA and allele A of rs3809865 were associated with a higher risk of stage 4 GC [OR = 1.85 (1.11-3.09), P = 0.012; and OR = 1.52 (0.99-2.33), P = 0.043, respectively]. For rs17664, GG genotype and allele G appeared to be associated with a higher risk with GC with lymphatic metastasis 3b [OR = 1.76 (1.00-3.11), P = 0.036; and OR = 1.64 (0.98-2.75), P = 0.048, respectively]. Our data suggest that polymorphisms of the microRNA-binding sites in the 3' UTR region of integrin are associated with GC susceptibility (rs2675), tumor stage (rs2675, rs17664, and rs3809865), and lymphatic metastasis (rs17664) in Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25472585     DOI: 10.1007/s13277-014-2903-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  49 in total

Review 1.  Role of integrins in cell invasion and migration.

Authors:  John D Hood; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

Review 2.  Integrins in development: moving on, responding to, and sticking to the extracellular matrix.

Authors:  Christian Bökel; Nicholas H Brown
Journal:  Dev Cell       Date:  2002-09       Impact factor: 12.270

3.  A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.

Authors:  Zhao-Hui Li; Xin-Min Pan; Bao-Wei Han; Xiao-Min Guo; Zhen Zhang; Jing Jia; Lin-Bo Gao
Journal:  Tumour Biol       Date:  2013-06-02

4.  Association between ITGA2 C807T polymorphism and gastric cancer risk.

Authors:  Jie Chen; Nan-Nan Liu; Jia-Qi Li; Li Yang; Ying Zeng; Xiao-Mei Zhao; Lin-Lin Xu; Xuan Luo; Bin Wang; Xue-Rong Wang
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

Review 5.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.

Authors:  O A Kent; J T Mendell
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

6.  The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling.

Authors:  Laura E Lamb; Jelani C Zarif; Cindy K Miranti
Journal:  Cancer Res       Date:  2011-02-10       Impact factor: 12.701

7.  Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.

Authors:  Konstantinos J Mavrakis; Andrew L Wolfe; Elisa Oricchio; Teresa Palomero; Kim de Keersmaecker; Katherine McJunkin; Johannes Zuber; Taneisha James; Aly A Khan; Christina S Leslie; Joel S Parker; Patrick J Paddison; Wayne Tam; Adolfo Ferrando; Hans-Guido Wendel
Journal:  Nat Cell Biol       Date:  2010-02-28       Impact factor: 28.824

8.  Expression of integrins α3β1 and α5β1 and GlcNAc β1,6 glycan branching influences metastatic melanoma cell migration on fibronectin.

Authors:  Ewa Pocheć; Marcelina Janik; Dorota Hoja-Łukowicz; Paweł Link-Lenczowski; Małgorzata Przybyło; Anna Lityńska
Journal:  Eur J Cell Biol       Date:  2013-11-01       Impact factor: 4.492

9.  Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.

Authors:  Annika Brendle; Haixin Lei; Andreas Brandt; Robert Johansson; Kerstin Enquist; Roger Henriksson; Kari Hemminki; Per Lenner; Asta Försti
Journal:  Carcinogenesis       Date:  2008-06-10       Impact factor: 4.944

10.  Genetic variation of ITGB3 is associated with asthma in Chinese Han children.

Authors:  Yan Zhang; Yuling Han; Liang Dong; Huafeng Yu; Lu Cheng; Xiuxia Zhao; Mingjie Ding
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more
  6 in total

1.  Anti-cancer effect of low dose of celecoxib may be associated with lnc-SCD-1:13 and lnc-PTMS-1:3 but not COX-2 in NCI-N87 cells.

Authors:  Bin Song; Zhen-Bo Shu; Juan Du; Ji-Chen Ren; Ye Feng
Journal:  Oncol Lett       Date:  2017-06-06       Impact factor: 2.967

2.  MicroRNAs in Genetic Etiology of Human Diseases.

Authors:  Melis Olcum; Kemal Ugur Tufekci; Sermin Genc
Journal:  Methods Mol Biol       Date:  2022

3.  Polymorphisms of microRNA target genes IL12B, INSR, CCND1 and IL10 in gastric cancer.

Authors:  Vytenis Petkevicius; Violeta Salteniene; Simonas Juzenas; Thomas Wex; Alexander Link; Marcis Leja; Ruta Steponaitiene; Jurgita Skieceviciene; Limas Kupcinskas; Laimas Jonaitis; Gediminas Kiudelis; Peter Malfertheiner; Juozas Kupcinskas
Journal:  World J Gastroenterol       Date:  2017-05-21       Impact factor: 5.742

4.  Expression and Prognostic Analysis of Integrins in Gastric Cancer.

Authors:  Jun-Fu Wang; Ye Wang; Si-Wen Zhang; Ye-Yang Chen; Yue Qiu; Shao-Yi Duan; Bo-Pei Li; Jun-Qiang Chen
Journal:  J Oncol       Date:  2020-11-30       Impact factor: 4.375

5.  Co-expressed differentially expressed genes and long non-coding RNAs involved in the celecoxib treatment of gastric cancer: An RNA sequencing analysis.

Authors:  Bin Song; Juan Du; Ye Feng; Yong-Jian Gao; Ji-Sheng Zhao
Journal:  Exp Ther Med       Date:  2016-09-01       Impact factor: 2.447

6.  Variant SNPs at the microRNA complementary site in the B7‑H1 3'‑untranslated region increase the risk of non‑small cell lung cancer.

Authors:  Wenwen Du; Jianjie Zhu; Yanbin Chen; Yuanyuan Zeng; Dan Shen; Nan Zhang; Weiwei Ning; Zeyi Liu; Jian-An Huang
Journal:  Mol Med Rep       Date:  2017-06-30       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.